{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:39:36Z","timestamp":1790692776275,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.bcp.2009.07.011","type":"journal-article","created":{"date-parts":[[2009,7,29]],"date-time":"2009-07-29T13:08:36Z","timestamp":1248872916000},"page":"1374-1381","source":"Crossref","is-referenced-by-count":83,"title":["Antiproliferative and antiangiogenic effects of the benzophenanthridine alkaloid sanguinarine in melanoma"],"prefix":"10.1016","volume":"78","author":[{"given":"Ilaria","family":"De Stefano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Raspaglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Franco","family":"Zannoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Travaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Prisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Mosca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiano","family":"Ferlini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Scambia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2009.07.011_bib1","unstructured":"Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002. Cancer incidence, mortality and prevalence worldwide. IARC Cancer Base No. 5 Version 2.0. Lyon, France: IARCPress; 2004."},{"key":"10.1016\/j.bcp.2009.07.011_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":"Cancer statistics","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.bcp.2009.07.011_bib3","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nature05661","article-title":"Melanoma biology and new targeted therapy","volume":"445","author":"Gray-Schopfer","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2009.07.011_bib4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1529-8019.2005.00052.x","article-title":"Cutaneous melanoma: available therapy for metastatic disease","volume":"19","author":"Tarhini","year":"2006","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.bcp.2009.07.011_bib5","doi-asserted-by":"crossref","first-page":"2331s","DOI":"10.1158\/1078-0432.CCR-05-2538","article-title":"Strategies for the development of more effective adjuvant therapy of melanoma: current and future explorations of antibodies, cytokines vaccines, and combinations","volume":"12","author":"Kirkwood","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2009.07.011_bib6","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.2174\/0929867013372094","article-title":"Advances in cancer therapy with plant based natural products","volume":"8","author":"Mukherjee","year":"2001","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bcp.2009.07.011_bib7","first-page":"1524","article-title":"Differential antiproliferative and apoptotic response of sanguinarine for cancer cells versus normal cells","volume":"6","author":"Ahmad","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2009.07.011_bib8","first-page":"737","article-title":"In vitro and in vivo activity of protein kinase C inhibitor chelerythrine chloride induces tumor cell toxicity and growth delay in vivo","volume":"6","author":"Chmura","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2009.07.011_bib9","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1158\/1535-7163.933.3.8","article-title":"Sanguinarine causes cell cycle blockade and apoptosis of human prostate carcinoma cells via modulation of cyclin kinase inhibitor-cyclin-cyclin-dependent kinase machinery","volume":"3","author":"Adhami","year":"2004","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bcp.2009.07.011_bib10","doi-asserted-by":"crossref","first-page":"30129","DOI":"10.1074\/jbc.272.48.30129","article-title":"Sanguinarine (pseudochelerythrine) is a potent inhibitor of NF-\u03baB activation, I\u03baB\u03b1 phosphorylation, and degradation","volume":"272","author":"Chaturvedi","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2009.07.011_bib11","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0006-2952(02)00902-4","article-title":"The alkaloid sanguinarine is effective against multidrug resistance in human cervical cells via bimodal cell death","volume":"63","author":"Ding","year":"2002","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2009.07.011_bib12","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.bcp.2008.07.013","article-title":"Sanguinarine cytotoxicity on mouse melanoma K1735-M2 cells\u2014nuclear vs. mitochondrial effects","volume":"76","author":"Serafim","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2009.07.011_bib13","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1096\/fasebj.1.5.3315805","article-title":"Fitting curves to data using nonlinear regression: a practical and nonmathematical review","volume":"1","author":"Motulsky","year":"1987","journal-title":"FASEB J"},{"key":"10.1016\/j.bcp.2009.07.011_bib14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.bcp.2004.09.004","article-title":"Thiocolchicine dimers: a novel class of topoisomerase-I inhibitors","volume":"69","author":"Raspaglio","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2009.07.011_bib15","doi-asserted-by":"crossref","first-page":"6406","DOI":"10.1021\/bi00344a014","article-title":"Effects of DNA intercalating agents on topoisomerase II induced DNA strand cleavage in isolated mammalian cell nuclei","volume":"24","author":"Pommier","year":"1985","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2009.07.011_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bjc.1998.1","article-title":"United Kingdom co-ordinating committee on cancer research (UKCCCR) guidelines for the welfare of animals in experimental neoplasia (Second Edition)","volume":"77","author":"Workman","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bcp.2009.07.011_bib17","series-title":"Anticancer drug development guide","first-page":"75","article-title":"In vivo methods for screening and preclinical testing","author":"Corbett","year":"1997"},{"key":"10.1016\/j.bcp.2009.07.011_bib18","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/01.gme.0000191208.05491.94","article-title":"Estradiol and phytoestrogens differently influence the rodent postmenopausal mammary gland","volume":"13","author":"Gallo","year":"2006","journal-title":"Menopause"},{"key":"10.1016\/j.bcp.2009.07.011_bib19","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/jn\/138.7.1360","article-title":"Soy phytochemicals decrease nonsmall cell lung cancer growth in female athymic mice","volume":"138","author":"Gallo","year":"2008","journal-title":"J Nutr"},{"key":"10.1016\/j.bcp.2009.07.011_bib20","first-page":"519","article-title":"A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor","volume":"67","author":"Passaniti","year":"1992","journal-title":"Lab Investig"},{"key":"10.1016\/j.bcp.2009.07.011_bib21","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/0014-5793(82)80152-X","article-title":"Sanguinarine: a monofunctional intercalation alkaloids","volume":"142","author":"Maiti","year":"1982","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bcp.2009.07.011_bib22","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cellbi.2007.09.004","article-title":"Differential effect of sanguinarine, chelerythrine and chelidonine on DNA damage and cell viability in primary mouse spleen cells and mouse leukemic cells","volume":"32","author":"Kaminskyy","year":"2008","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.bcp.2009.07.011_bib23","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10565-006-0109-x","article-title":"The effect of chelerythrine on cell growth, apoptosis, and cell cycle in human normal and cancer cells in comparison with sanguinarine","volume":"22","author":"Mal\u00edkov\u00e1","year":"2006","journal-title":"Cell Biol Toxicol"},{"key":"10.1016\/j.bcp.2009.07.011_bib24","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.2741\/1755","article-title":"The RAS\/RAF\/MEK\/ERK and PI3K\/AKT signaling pathways present molecular targets for the effective treatment of advanced melanoma","volume":"10","author":"Meier","year":"2005","journal-title":"Front Biosci"},{"key":"10.1016\/j.bcp.2009.07.011_bib25","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/CAD.0b013e328117f463","article-title":"Induction of apoptosis by sanguinarine in C6 rat glioblastoma cells is associated with the modulation of the Bcl-2 family and activation of caspases through downregulation of extracellular signal-regulated kinase and Akt","volume":"18","author":"Han","year":"2007","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.bcp.2009.07.011_bib26","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/jcb.21672","article-title":"Sanguinarine-induced apoptosis: generation of ROS, down-regulation of Bcl-2, c-FLIP, and synergy with TRAIL","volume":"104","author":"Kim","year":"2008","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.bcp.2009.07.011_bib27","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.bbrc.2004.03.077","article-title":"Suppression of angiogenesis by the plant alkaloid, sanguinarine","volume":"317","author":"Eun","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bcp.2009.07.011_bib28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/biof.5520290102","article-title":"Sanguinarine inhibits VEGF-induced angiogenesis in a fibrin gel matrix","volume":"29","author":"Basini","year":"2007","journal-title":"Biofactors"},{"key":"10.1016\/j.bcp.2009.07.011_bib29","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrc2403","article-title":"VEGF-targeted therapy: mechanisms of anti-tumour activity","volume":"8","author":"Ellis","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bcp.2009.07.011_bib30","first-page":"753","article-title":"Dacarbazine causes transcriptional up-regulation of interleukin 8 and vascular endothelial growth factor in melanoma cells: a possible escape mechanism from chemotherapy","volume":"2","author":"Lev","year":"2003","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bcp.2009.07.011_bib31","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1200\/JCO.2004.11.070","article-title":"Exposure of melanoma cells to dacarbazine results in enhanced tumor growth and metastasis in vivo","volume":"22","author":"Lev","year":"2004","journal-title":"J Clin Oncol"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295209006431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295209006431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T05:18:11Z","timestamp":1685078291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295209006431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0006295209006431"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2009.07.011","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}